Improved Purification Process for Cholera Toxin and its Application to the Quantification of Residual Toxin in Cholera Vaccines
![]() |
Jang, Hyun
(Vaccine Development Section, Laboratory Sciences Division, International Vaccine Institute)
Kim, Hyo-Seung (Vaccine Development Section, Laboratory Sciences Division, International Vaccine Institute) Kim, Jeong-Ah (Vaccine Development Section, Laboratory Sciences Division, International Vaccine Institute) Seo, Jin-Ho (Department of Biochemical Engineering, Seoul National University) Carbis, Rodney (Vaccine Development Section, Laboratory Sciences Division, International Vaccine Institute) |
1 | Kurosky, A., D. E. Markel, B. Touchstone, and J. W. Peterson. 1976. Chemical characterization of the structure of cholera toxin and its natural toxoid. J. Infect. Dis. 133(Suppl): S14-S24 DOI |
2 | Laurell, C.-B. 1966. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochemis. 15: 45-52 DOI PUBMED ScienceOn |
3 |
Tayot, J.-L., J. Holmgren, L. Svennerholm, M. Lindblad, and M. Tardy. 1981. Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with |
4 |
Turnbull, P. C., J. V. Lee, M. D. Miliotis, C. S. Still, M. Isa |
5 | WHO Expert Committee on Biological Standardization. 2004. WHO Technical Report, Series No. 924 |
6 | Dawson, R. M. 2005. Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates. J. Appl. Toxicol. 25: 30-38 DOI ScienceOn |
7 | Lonnroth, I. and J. Holmgren. 1973. Subunit structure of cholera toxin. J. Gen. Microbiol. 76: 417-427 DOI PUBMED ScienceOn |
8 | Anh, D. D., D. G. Canh, A. L. Lopez, V. D. Thiem, P. T. Long, H. H. Son, et al. 2007. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine 25: 1149-1155 DOI ScienceOn |
9 | Holmgren, J. and A. M. Svennerholm. 1973. Enzyme-linked immunosorbent assays for cholera serology. Infect. Immun. 7:759-763 PUBMED |
10 | Slos, P., D. Speck, N. Accart, H. V. J. Kolbe, D. Schubnel, B. Bouchon, R. Bischoff, and M. P. Kieny. 1994. Recombinant cholera toxin B-subunit in Escherichia coli: High-level secretion, purification, and characterization. Protein Express. Purif. 5:518-526 DOI ScienceOn |
11 | Osek, J., M. Lebens, and J. Holmgren.1995. Improved medium for large-scale production of recombinant cholera toxin B subunit for vaccine purposes. J. Microbiol. Methods 24: 117-123 DOI ScienceOn |
12 | Walker, R. I. 2005. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 23: 3369-3385 DOI PUBMED ScienceOn |
13 | Gill, D. M. 1976. The arrangement of subunits in cholera toxin. Biochemistry 15: 1242-1248 DOI PUBMED ScienceOn |
14 | Lowry, O. H., N. J. Rosebrough, A. C. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275 PUBMED |
15 | Cuatrecasas, P. 1973. Vibrio cholerae choleragenoid. Mechanism of inhibition of cholera toxin action. Biochemistry 15: 3577-3781 DOI ScienceOn |
16 | Girard, M. P., D. Steele, C.-L. Chaignat, and M. P. Kieny. 2006. A review of vaccine research and development: Human enteric infections. Vaccine 24: 2732-2750 DOI ScienceOn |
17 | Mekalanos, J. J. 1988. Production and purification of cholera toxin. Methods Enzymol. 165: 169-175 DOI PUBMED ScienceOn |
18 | Clemens, J., D. A. Sack, J. R. Harris, F. van Loon, J. Chakraborty, F. Ahmed, et al. 1990. Field trial of oral cholera vaccine in Bangladesh: Results from three-year follow-up. Lancet 335: 270-273 DOI ScienceOn |
19 | Holmgren, J. 1973. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect. Immun. 8: 851-859 PUBMED |
20 | Mekalanos, J. J., R. J. Collier, and W. R. Romig. 1978. Purification of cholera toxin and its subunits: New methods of preparation and the use of hypertoxinogenic mutants. Infect. Immun. 20: 552-558 PUBMED |
21 | Holmgren, J. 1981. Action of cholera toxin and the prevention and treatment of cholera. Nature 292: 413-417 DOI PUBMED ScienceOn |
22 | Rappaport, R. S., B. A. Rubin, and H. Tint. 1974. Development of a purified cholera toxoid. I. Purification of toxin. Infect. Immun. 9: pp. 294-303 PUBMED |
![]() |